These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 38863031)
21. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351 [TBL] [Abstract][Full Text] [Related]
22. Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma. Lee YE; Lee J; Lee YS; Jang JJ; Woo H; Choi HI; Chai YG; Kim TK; Kim T; Kim LK; Choi SS Mol Cells; 2021 Sep; 44(9):658-669. PubMed ID: 34588321 [TBL] [Abstract][Full Text] [Related]
23. Functional roles of antisense enhancer RNA for promoting prostate cancer progression. Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781 [No Abstract] [Full Text] [Related]
24. Genetic Variants That Impact Alternative Polyadenylation in Cancer Represent Candidate Causal Risk Loci. Li B; Cai Y; Chen C; Li G; Zhang M; Lu Z; Zhang F; Huang J; Fan L; Ning C; Li Y; Wang W; Geng H; Liu Y; Chen S; Li H; Yang S; Zhang H; Tian W; Zhu Z; Xu B; Li H; Li H; Jin M; Wang X; Zhang S; Liu J; Huang C; Yang X; Wei Y; Zhu Y; Tian J; Miao X Cancer Res; 2023 Nov; 83(21):3650-3666. PubMed ID: 37669142 [TBL] [Abstract][Full Text] [Related]
25. Enhancer RNA (eRNA) in Human Diseases. Wang Y; Zhang C; Wang Y; Liu X; Zhang Z Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232885 [TBL] [Abstract][Full Text] [Related]
26. Enhancer-derived RNA: A Primer. Liu F Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):196-200. PubMed ID: 28533025 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects. Wan L; Li W; Meng Y; Hou Y; Chen M; Xu B Front Immunol; 2022; 13():849451. PubMed ID: 35514959 [TBL] [Abstract][Full Text] [Related]
29. Enforced Activation of Enhancer RNAs In Situ through the dCas9 Synergistic Activation Mediator System. Liao Z; Lee JH; Krakowiak J; Wang R; Li W J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568241 [TBL] [Abstract][Full Text] [Related]
30. Enhancer RNA: biogenesis, function, and regulation. Ye R; Cao C; Xue Y Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351 [TBL] [Abstract][Full Text] [Related]
31. Pig-eRNAdb: a comprehensive enhancer and eRNA dataset of pigs. Wang Y; Jin W; Pan X; Liao W; Shen Q; Cai J; Gong W; Tian Y; Xu D; Li Y; Li J; Gong J; Zhang Z; Yuan X Sci Data; 2024 Feb; 11(1):157. PubMed ID: 38302497 [TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues. Cheng JH; Pan DZ; Tsai ZT; Tsai HK Sci Rep; 2015 Jul; 5():12648. PubMed ID: 26219400 [TBL] [Abstract][Full Text] [Related]
33. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer. Wang R; Tang Q Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073237 [TBL] [Abstract][Full Text] [Related]
34. Implications of Enhancer Transcription and eRNAs in Cancer. Adhikary S; Roy S; Chacon J; Gadad SS; Das C Cancer Res; 2021 Aug; 81(16):4174-4182. PubMed ID: 34016622 [TBL] [Abstract][Full Text] [Related]
35. Super enhancer loci of EGFR regulate EGFR variant 8 through enhancer RNA and strongly associate with survival in HNSCCs. Chakkarappan SR; Umadharshini KV; Dhamodharan S; Rose MM; Gopu G; Murugan AK; Inoue I; Munirajan AK Mol Genet Genomics; 2024 Jan; 299(1):3. PubMed ID: 38236481 [TBL] [Abstract][Full Text] [Related]
36. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation. Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725 [TBL] [Abstract][Full Text] [Related]
37. HSPA12A was identified as a key driver in colorectal cancer GWAS loci 10q26.12 and modulated by an enhancer-promoter interaction. Lu Z; Fan L; Zhang F; Huang C; Cai Y; Chen C; Li G; Zhang M; Huang J; Ning C; Li Y; Wang W; Geng H; Liu Y; Chen S; Li H; Yang S; Zhang H; Tian W; Ye T; Liu J; Yang X; Xu B; Zhu Y; Zhong R; Li H; Tian J; Li B; Miao X Arch Toxicol; 2023 Jul; 97(7):2015-2028. PubMed ID: 37245169 [TBL] [Abstract][Full Text] [Related]
38. Multi-omics analysis reveals the functional transcription and potential translation of enhancers. Wu Y; Yang Y; Gu H; Tao B; Zhang E; Wei J; Wang Z; Liu A; Sun R; Chen M; Fan Y; Mao R Int J Cancer; 2020 Oct; 147(8):2210-2224. PubMed ID: 32573785 [TBL] [Abstract][Full Text] [Related]
39. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression. Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730 [TBL] [Abstract][Full Text] [Related]
40. Population-level variation in enhancer expression identifies disease mechanisms in the human brain. Dong P; Hoffman GE; Apontes P; Bendl J; Rahman S; Fernando MB; Zeng B; Vicari JM; Zhang W; Girdhar K; Townsley KG; Misir R; ; Brennand KJ; Haroutunian V; Voloudakis G; Fullard JF; Roussos P Nat Genet; 2022 Oct; 54(10):1493-1503. PubMed ID: 36163279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]